CD47 and neoplasm: Anti‐CD8 depleting antibody in conjugation with CD47 × PD‐L1 BisAb treatment resulted in the ablation of CD8+ T cells within the spleen and tumor (Figure 3a and b) and led to an outgrowth of AT3‐OVA tumors equivalent to that observed in isotype‐treated mice (Figure 3c and d).